Alzamend Neuro, Inc. — Form D
Alzamend Neuro, Inc. of TAMPA, FL, a company, filed a Form D exempt-offering notice with the SEC on 2019-04-23. The offering totals $2.0M, of which $232K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-04-23
- Form: D
- Accession: 0001214659-19-002838
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $232K
- Remaining: $1.8M
- Minimum investment: $999
- Investors: 17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-337858
Issuer
- Name: Alzamend Neuro, Inc.
- CIK: 0001677077
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 3802 SPECTRUM BLVD, SUITE 112C, TAMPA, FL, 33612
- Phone: 844-722-6333
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Milton C. Ault | Related Person | Tampa, FL |
| Kenneth S. Cragun | Related Person | Tampa, FL |
| William B. Horne | Related Person | Tampa, FL |
| Stephan Jackman | Related Person | Tampa, FL |
| Philip E. Mansour | Related Person | Tampa, FL |
| Milton C Ault | Director | Las Vegas, NV |
| Stephan Jackman | Executive Officer | Tampa, FL |
| Philip E Mansour | Director | Tampa, FL |
| Milton C Ault III | Director | Salt Lake City, UT |
| Philip Mansour | Director | Salt Lake City, UT |
| Philip Mansour | Executive Officer | Salt Lake City, UT |
| William B Horne | Director | Salt Lake City, UT |
| William B Horne | Executive Officer | Salt Lake City, UT |
| Kenneth S Cragun | Executive Officer | Irvine, CA |
Other filings by this issuer (2)
More